Literature DB >> 22469107

Development of a sensitive prognostic scoring system for the evaluation of severity of acute-on-chronic hepatitis B liver failure: a retrospective cohort study.

Yu-Bao Zheng1, Dong-Ying Xie, Yu-Rong Gu, Ying Yan, Ye-Bin Wu, Zi-Ying Lei, Liang Peng, Shi-Bin Xie, Zhi-liang Gao, Wei-min Ke.   

Abstract

PURPOSE: The purpose of the current study was to establish an objective, simple, and sensitive prognostic scoring system for estimating the severity of acute-on-chronic liver failure in hepatitis B (ACLFB).
METHODS: A novel prognostic scoring system was calculated from six clinical indices including total bilirubin (TB), prothrombin activity (PTA), creatinine (Cr), hepatic encephalopathy (HE), infections, and the depth of ascites from 726 patients with ACLFB. Indices were scored from 1 to 4 according to their severity. Groups of the same patients were scored with three-indices (TB, PTA and Cr), four-indices (TB, PTA, Cr and HE), five-indices (TB, PTA, Cr, HE and the depth of ascites) or six-indices (TB, PTA, Cr, HE, the depth of ascites, and infections). The differences in the sensitivity and specificity of four scoring systems were analyzed.
RESULTS: The demarcation points of the three-, four-, five- and six-indices scoring systems were 4.62, 6.12, 7.88 and 9.57, respectively. The analysis of the areas under the receiver operating characteristic (ROC) curve indicated that the four-, five- and six-indices scoring systems were more exact, and objective than the three-indices prognostic scoring system. In the six-indices scoring system, the survival rates of patients with scores from 2 to 6 was 98.31% (233/237), and the mortality rate of patients with scores of 16 and above was 100.00% (140/140), while the mortality rates were 8.33% (3/36) and 96.43% (27/28) for those with scores from 7 to 15, respectively.
CONCLUSION: A six-indices scoring system is an objective, pertinent, and sensitive system, and may be useful for the prognostic evaluation of ACLFB.

Entities:  

Mesh:

Year:  2012        PMID: 22469107     DOI: 10.25011/cim.v35i2.16291

Source DB:  PubMed          Journal:  Clin Invest Med        ISSN: 0147-958X            Impact factor:   0.825


  5 in total

1.  Gut microbiota as prognosis markers for patients with HBV-related acute-on-chronic liver failure.

Authors:  Ke Wang; Zhao Zhang; Zhi-Shuo Mo; Xiao-Hua Yang; Bing-Liang Lin; Liang Peng; Yang Xu; Chun-Yan Lei; Xiao-Dong Zhuang; Ling Lu; Rui-Fu Yang; Tao Chen; Zhi-Liang Gao
Journal:  Gut Microbes       Date:  2021 Jan-Dec

2.  Dynamic changes of clinical features that predict the prognosis of acute-on-chronic hepatitis B liver failure: a retrospective cohort study.

Authors:  Yu-Bao Zheng; Zhan Lian Huang; Zhe Bin Wu; Min Zhang; Yu Rong Gu; Yu Jie Su; Chao Shuang Lin; Rui Hua Zhu; Bin Liang Lin; Zhi Liang Gao
Journal:  Int J Med Sci       Date:  2013-09-23       Impact factor: 3.738

3.  Serum sphingolipids reflect the severity of chronic HBV infection and predict the mortality of HBV-acute-on-chronic liver failure.

Authors:  Feng Qu; Su-Jun Zheng; Shuang Liu; Cai-Sheng Wu; Zhong-Ping Duan; Jin-Lan Zhang
Journal:  PLoS One       Date:  2014-08-19       Impact factor: 3.240

4.  A comprehensive validation of HBV-related acute-on-chronic liver failure models to assist decision-making in targeted therapeutics.

Authors:  Yi Shen; Xulin Wang; Sheng Zhang; Gang Qin; Yanmei Liu; Yihua Lu; Feng Liang; Xun Zhuang
Journal:  Sci Rep       Date:  2016-09-16       Impact factor: 4.379

5.  Serum Glycopatterns as Novel Potential Biomarkers for Diagnosis of Acute-on-Chronic Hepatitis B Liver Failure.

Authors:  Yaogang Zhong; Yonghong Guo; Xiawei Liu; Jiaxu Zhang; Tianran Ma; Jian Shu; Jiajun Yang; Jing Zhang; Zhansheng Jia; Zheng Li
Journal:  Sci Rep       Date:  2017-04-06       Impact factor: 4.379

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.